Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn
Condition(s):Ornithine Transcarbamylase DeficiencyLast Updated:November 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Ornithine Transcarbamylase DeficiencyLast Updated:November 7, 2023Recruiting
Condition(s):Ornithine Transcarbamylase DeficiencyLast Updated:April 7, 2023Active, not recruiting
Condition(s):Ornithine Transcarbamylase DeficiencyLast Updated:September 17, 2019Withdrawn
Condition(s):Ornithine Transcarbamylase DeficiencyLast Updated:March 8, 2024Completed
Condition(s):Ornithine Transcarbamylase Deficiency; Wilson Disease; Glycogen Storage Disease Type IALast Updated:June 12, 2023Terminated
Condition(s):Ornithine Transcarbamylase Deficiency; OTC Deficiency; OTCDLast Updated:April 7, 2023Recruiting
Condition(s):Ornithine Transcarbamylase Deficiency DiseaseLast Updated:March 25, 2015Terminated
Condition(s):Ornithine Transcarbamylase Deficiency DiseaseLast Updated:June 24, 2005Terminated
Condition(s):Ornithine Transcarbamylase Deficiency; Ornithine Transcarbamylase Deficiency Disease; Ornithine Carbamoyltransferase Deficiency (Disorder); Urea Cycle Disorders, InbornLast Updated:February 13, 2024Not yet recruiting
Condition(s):Ornithine Transcarbamylase (OTC) DeficiencyLast Updated:January 25, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.